These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19156549)

  • 1. Phenoxodiol treatment alters the subsequent response of ENOX2 (tNOX) and growth of hela cells to paclitaxel and cisplatin.
    Morré DJ; McClain N; Wu LY; Kelly G; Morré DM
    Mol Biotechnol; 2009 May; 42(1):100-9. PubMed ID: 19156549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
    De Luca T; Morré DM; Morré DJ
    J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
    Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
    Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENOX2 target for the anticancer isoflavone ME-143.
    Morré DJ; Korty T; Meadows C; Ades LM; Morré DM
    Oncol Res; 2014; 22(1):1-12. PubMed ID: 25700353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol.
    Wu LY; De Luca T; Watanabe T; Morré DM; Morré DJ
    Biochim Biophys Acta; 2011 Aug; 1810(8):784-9. PubMed ID: 21571040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol.
    De Luca T; Bosneaga E; Morré DM; Morré DJ
    Biofactors; 2008; 34(3):253-60. PubMed ID: 19734127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
    Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
    Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.
    McPherson RA; Galettis PT; de Souza PL
    Br J Cancer; 2009 Feb; 100(4):649-55. PubMed ID: 19209173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
    Yagiz K; Wu LY; Kuntz CP; James Morré D; Morré DM
    J Cell Biochem; 2007 May; 101(2):295-306. PubMed ID: 17115410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
    Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
    Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on a tumor-associated NADH oxidase in gastric cancer cell growth.
    Cheng HL; Lee YH; Yuan TM; Chen SW; Chueh PJ
    World J Gastroenterol; 2016 Mar; 22(10):2900-5. PubMed ID: 26973386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.
    Axanova L; Morré DJ; Morré DM
    Cancer Lett; 2005 Jul; 225(1):35-40. PubMed ID: 15922855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
    Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.
    Alvero AB; O'Malley D; Brown D; Kelly G; Garg M; Chen W; Rutherford T; Mor G
    Cancer; 2006 Feb; 106(3):599-608. PubMed ID: 16388521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Ishibashi H; Kato K; Iwahashi H; Takasaki K; Kuwahara M; Matuura H; Sakamoto T; Yoshikawa T; Furuya K
    Anticancer Res; 2018 Jan; 38(1):301-306. PubMed ID: 29277787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
    Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
    Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
    Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
    Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated NADH oxidase (tNOX)-NAD+-sirtuin 1 axis contributes to oxaliplatin-induced apoptosis of gastric cancer cells.
    Chen HY; Cheng HL; Lee YH; Yuan TM; Chen SW; Lin YY; Chueh PJ
    Oncotarget; 2017 Feb; 8(9):15338-15348. PubMed ID: 28122359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis.
    De Luca T; Morré DM; Zhao H; Morré DJ
    Biofactors; 2005; 25(1-4):43-60. PubMed ID: 16873929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model.
    Klein R; Brown D; Turnley AM
    BMC Neurosci; 2007 Aug; 8():61. PubMed ID: 17672914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.